TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) SEC News March 13, 2026, 10:01 UTC (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot March 13, 2026, 12:05 p.m. 📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Financial Results Filing Date: 2026-03-13 Accepted: 2026-03-13 06:01:04 Event Type: Financial Results Event Details: TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Reports the reporting period Financial Results TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: Not disclosed Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: Not disclosed 📊 Key Financial Metrics: Metric Value 💼 Business Developments: No business developments data available. Structured Data: Company Name: TONIX PHARMACEUTICALS HOLDING CORP.Ticker Symbol: TNXP
📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Financial Results
Filing Date: 2026-03-13
Accepted: 2026-03-13 06:01:04
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
No business developments data available.
Structured Data: